Document Actions

Dr Philip Lowden

BSc, MSc, PhD
Lecturer in Chemistry

Contact details

tel: +44 (0)20 7079 0789
fax: +44 (0)20 7631-6246
email: p.lowden@bbk.ac.uk
Room 313b, Department of Biological Sciences, main building, Malet Street, London.

About Dr Philip Lowden

Publications

  • Corre C., Lowden P.A.S. (2003) The first biosynthetic studies on the azinomycins. Submitted to Chemical Communications.
  • Lowden P.A.S., Böhm G.A., Metcalfe S., Staunton J. Leadlay P.F. (2003). New rapamycin derivatives by precursor-directed biosynthesis. Accepted for publication in ChemBioChem.
  • Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X.B., Rosa E., Sathasivam K., Ghazi-Noori S., Mahal A., Lowden P.A.S., Steffan J.S., Marsh J.L., Thompson L.M., Lewis C.M., Marks P.A., Bates G.P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 100(4):2041-2046.
  • Smith D.L., Woodman B., Mahal A., Sathasivam K., Ghazi-Noori S., Lowden P.A.S., Bates G.P., Hockly E. (2003) Minocycline and doxycycline are not beneficial in a model of Huntington's disease. Annals of Neurology 54(2):186-196.
  • Giles G.I., Giles N.M., Collins C.A., Holt K., Fry F.H., Lowden P.A.S., Gutowski N.J., Jacob C. (2003). Electrochemical, in vitro and cell culture analysis of integrated redox catalysts: implications for cancer therapy. Chemical Communications (16):2030-2031.